Does Rallies show 13F holders for RGEN?

Yes. Rallies tracks hedge fund and 13F ownership data for RGEN, including fund names, share counts, latest tracked quarter, and position changes when available.

Is RGEN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for RGEN. It does not provide personalized investment advice.

RGEN (Repligen Corp) Stock Analysis - Hedge Fund Holdings

Repligen Corp (RGEN) is a publicly traded Healthcare sector company. As of May 20, 2026, RGEN trades at $108.55 with a market cap of $5.88B and a P/E ratio of 117.84. RGEN moved -1.01% today. Year to date, RGEN is -33.97%; over the trailing twelve months it is -14.00%. Its 52-week range spans $100.99 to $182.52. Analyst consensus is strong buy with an average price target of $176.23. Rallies surfaces RGEN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns RGEN stock?

Hedge funds tracked by Rallies that own RGEN include Maverick Capital, Eisler Capital, Bridgewater Associates, Centerbook Partners, and Pinebridge Investments. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Repligen Corp.

RGEN Key Metrics

Key financial metrics for RGEN
Metric	Value
Price	$108.55
Market Cap	$5.88B
P/E Ratio	117.84
EPS	$0.92
Dividend Yield	0.00%
52-Week High	$182.52
52-Week Low	$100.99
Volume	291.67K
Avg Volume	0
Revenue (TTM)	$763.34M
Net Income	$51.40M
Gross Margin	52.90%

Top Hedge Funds Holding RGEN

Maverick Capital holds 1.52M shares of RGEN, changed +0.00% as of Mar 31, 2026.
Eisler Capital holds 20.78K shares of RGEN, changed +1246.79% as of Mar 31, 2024.
Bridgewater Associates holds 7.87K shares of RGEN, changed -76.58% as of Dec 31, 2025.
Centerbook Partners holds 6.38K shares of RGEN, changed -63.90% as of Mar 31, 2026.
Pinebridge Investments holds 5.43K shares of RGEN, changed -70.04% as of Mar 31, 2025.

Latest RGEN News

Repligen's 2025 Sustainability Report Highlights 100% Renewable Power, 14% Water Reduction — May 20, 2026
Repligen jumps after Q1 beat and higher 2026 adjusted EPS outlook — May 6, 2026
Repligen Q1 Revenue Up 15% to $194M, EPS Beats and Raises Guidance — May 5, 2026
Repligen Q1 Revenue Up 15% to $194M; Raises FY26 EPS to $1.97-$2.05 — May 5, 2026
Repligen rises ahead of May 5 Q1 earnings, with FY2026 guidance in focus — Apr 30, 2026

Recent RGEN Insider Trades

Loeillot Olivier sold 3.83K (~$536.48K) on Apr 21, 2026.
DAWES KAREN A sold 275 (~$44.27K) on Dec 17, 2025.
Loeillot Olivier sold 7.04K (~$1.20M) on Nov 25, 2025.

RGEN Analyst Consensus

15 analysts cover RGEN: 0 strong buy, 12 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $176.23.

Common questions about RGEN

Who owns RGEN stock?: Hedge funds tracked by Rallies that own RGEN include Maverick Capital, Eisler Capital, Bridgewater Associates, Centerbook Partners, and Pinebridge Investments. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Repligen Corp.
Does Rallies show 13F holders for RGEN?: Yes. Rallies tracks hedge fund and 13F ownership data for RGEN, including fund names, share counts, latest tracked quarter, and position changes when available.
Is RGEN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for RGEN. It does not provide personalized investment advice.